美国 · SEC FORM 4
COOPER COMPANIES, INC.
COO · Nasdaq · CIK 0000711404 · Healthcare · Medical Instruments & Supplies
内部人信号
3 位买方 · 5 条买入交易行 · $1.9M 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
- ✓ 角色得分高 · 买入者中职位最高的是：Director
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 77.1
- 77.0
- 76.9
- 76.7
- 76.5
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- +0.4%
- 3M
- -23.8%
- 6M
- -23.6%
- 12M
- -22.6%
波动率与流动性
- 波动率
- 33.4%
- Beta
- —
- 平均每日成交额
- USD 175.8M
估值
- 市值
- USD 10.3B
- P/E
- 27.6×
基本面
- 利润率
- 9.2%
- ROE
- 4.6%
- 细分行业
- Medical Instruments & Supplies
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, P/E, 利润率, ROE · 财年截止日：2025-10-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-09-03 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 8,331,649
- 上期报告
- 10,008,627
- 日均成交量
- 5,042,960
- 回补天数
- 1.6
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 10,000 | USD 54.93 | USD 549,300 | SEC 申报 ↗ |
| 2026-09-14 | Rosebrough Walter M Jr | 买入 (P) | Common Stock | 3,000 | USD 54.29 | USD 162,870 | SEC 申报 ↗ |
| 2026-09-14 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 10,000 | USD 53.92 | USD 539,200 | SEC 申报 ↗ |
| 2026-09-11 | Rosebrough Walter M Jr | 买入 (P) | Common Stock | 7,000 | USD 54.11 | USD 378,770 | SEC 申报 ↗ |
| 2026-09-11 | Keel Paul A | 买入 (P) | Common Stock | 4,701 | USD 53.18 | USD 250,000 | SEC 申报 ↗ |
| 2025-12-22 | Lucchese Cynthia L | 买入 (P) | Common Stock | 1,784 | USD 84.06 | USD 149,963 | SEC 申报 ↗ |
| 2025-12-18 | Rivas Maria | 买入 (P) | Common Stock | 1,000 | USD 82.13 | USD 82,130 | SEC 申报 ↗ |
| 2025-12-17 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 2,000 | USD 82.50 | USD 165,000 | SEC 申报 ↗ |
| 2025-12-16 | White Albert G III | 买入 (P) | Common Stock | 10,000 | USD 80.80 | USD 808,000 | SEC 申报 ↗ |
| 2025-12-16 | Sheffield Holly R | 买入 (P) | Common Stock | 1,230 | USD 80.75 | USD 99,322 | SEC 申报 ↗ |
| 2025-09-29 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 2,000 | USD 68.39 | USD 136,780 | SEC 申报 ↗ |
| 2025-09-05 | White Albert G III | 买入 (P) | Common Stock | 10,000 | USD 68.39 | USD 683,900 | SEC 申报 ↗ |
| 2025-09-05 | Warner Gerard H III | 买入 (P) | Common Stock | 1,450 | USD 69.23 | USD 100,384 | SEC 申报 ↗ |
| 2025-09-02 | McBride Daniel G | 买入 (P) | Common Stock | 3,000 | USD 65.04 | USD 195,120 | SEC 申报 ↗ |
| 2025-09-02 | Andrews Brian G | 买入 (P) | Common Stock | 1,525 | USD 65.68 | USD 100,162 | SEC 申报 ↗ |
Form 4 申报证据
46 transaction lines in the latest 365-day window; 480 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 10,000 | USD 54.93 | USD 549,300 | SEC 申报 ↗ |
| 2026-09-14 | Rosebrough Walter M Jr | 买入 (P) | Common Stock | 3,000 | USD 54.29 | USD 162,870 | SEC 申报 ↗ |
| 2026-09-14 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 10,000 | USD 53.92 | USD 539,200 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 10,000 | USD 54.93 | USD 549,300 | SEC 申报 ↗ |
| 2026-09-14 | Rosebrough Walter M Jr | 买入 (P) | Common Stock | 3,000 | USD 54.29 | USD 162,870 | SEC 申报 ↗ |
| 2026-09-14 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 10,000 | USD 53.92 | USD 539,200 | SEC 申报 ↗ |
| 2026-09-11 | Rosebrough Walter M Jr | 买入 (P) | Common Stock | 7,000 | USD 54.11 | USD 378,770 | SEC 申报 ↗ |
| 2026-09-11 | Keel Paul A | 买入 (P) | Common Stock | 4,701 | USD 53.18 | USD 250,000 | SEC 申报 ↗ |
| 2026-04-01 | Rosebrough Walter M Jr | 期权行权／转换 (M) | Common Stock | 832 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-01 | WEISS ROBERT S | 期权行权／转换 (M) | Common Stock | 3,654 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-01 | Rivas Maria | 期权行权／转换 (M) | Common Stock | 3,322 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-01 | MADDEN TERESA S | 期权行权／转换 (M) | Common Stock | 3,322 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-01 | Lucchese Cynthia L | 期权行权／转换 (M) | Common Stock | 3,322 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-01 | Kurzius Lawrence Erik | 期权行权／转换 (M) | Common Stock | 3,322 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-01 | Jay Colleen | 期权行权／转换 (M) | Common Stock | 3,322 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-01 | Carbone Barbara | 期权行权／转换 (M) | Common Stock | 3,050 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-12 | Jay Colleen | 期权行权／转换 (M) | Common Stock | 7,064 | USD 39.40 | USD 278,322 | SEC 申报 ↗ |
| 2026-01-08 | White Albert G III | 期权行权／转换 (M) | Common Stock | 18,340 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-08 | White Albert G III | 代扣税 (F) | Common Stock | 9,419 | USD 83.13 | USD 783,001 | SEC 申报 ↗ |
| 2026-01-08 | Warner Gerard H III | 期权行权／转换 (M) | Common Stock | 11,518 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-08 | Warner Gerard H III | 代扣税 (F) | Common Stock | 5,985 | USD 83.13 | USD 497,533 | SEC 申报 ↗ |
| 2026-01-08 | Sheffield Holly R | 期权行权／转换 (M) | Common Stock | 8,050 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-08 | Sheffield Holly R | 代扣税 (F) | Common Stock | 3,841 | USD 83.13 | USD 319,302 | SEC 申报 ↗ |
| 2026-01-08 | McBride Daniel G | 期权行权／转换 (M) | Common Stock | 12,887 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-08 | McBride Daniel G | 代扣税 (F) | Common Stock | 6,655 | USD 83.13 | USD 553,230 | SEC 申报 ↗ |
| 2026-01-08 | Andrews Brian G | 期权行权／转换 (M) | Common Stock | 3,528 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-08 | Andrews Brian G | 代扣税 (F) | Common Stock | 1,893 | USD 83.13 | USD 157,365 | SEC 申报 ↗ |
| 2025-12-22 | Lucchese Cynthia L | 买入 (P) | Common Stock | 1,784 | USD 84.06 | USD 149,963 | SEC 申报 ↗ |
| 2025-12-18 | Rivas Maria | 买入 (P) | Common Stock | 1,000 | USD 82.13 | USD 82,130 | SEC 申报 ↗ |
| 2025-12-17 | Kurzius Lawrence Erik | 买入 (P) | Common Stock | 2,000 | USD 82.50 | USD 165,000 | SEC 申报 ↗ |
| 2025-12-16 | White Albert G III | 买入 (P) | Common Stock | 10,000 | USD 80.80 | USD 808,000 | SEC 申报 ↗ |
| 2025-12-16 | Sheffield Holly R | 买入 (P) | Common Stock | 1,230 | USD 80.75 | USD 99,322 | SEC 申报 ↗ |
| 2025-12-12 | WEISS ROBERT S | 赠与 (G) | Common Stock | 7,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | COO |
| CIK | 0000711404 |
| 行业 | Healthcare |
| 细分行业 | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3851 Ophthalmic Goods |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 480 transaction lines from 2020-01-02 to 2026-09-16 20 P purchase lines · 79 S sale lines · 381 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.